
International Epilepsy Day 2026: Highlighting Gaps in Pediatric Care, Stigma, and Education
Pediatric neurologist Charuta Joshi, MD, discussed global disparities in epilepsy for children and adolescents amid International Epilepsy Day, highlighting opportunities for education, stigma reduction, and improved care access.
International Epilepsy Day, held February 9, 2026, is a global awareness event that aims to unite clinicians, patient advocates, and communities to narrow these health disparities, especially for pediatric epilepsy. By fostering open discussion, challenging stigma, and promoting policies that expand access to diagnosis and treatment, this internationally celebrated observance affirms that geography should not bar patients from the care they need.
In honor of the awareness day, NeurologyLive® spoke with Charuta Joshi, MD, president of the
NeurologyLive: What educational gaps still need to be addressed to improve pediatric epilepsy diagnosis and long-term management internationally?
Charuta Joshi, MD: Although more than 50 million people worldwide have epilepsy, 80% live in low middle income countries with an appallingly insufficient workforce. General and mid-level practitioners in these areas need to be empowered with tools to talk about the fact that epilepsy is among the top 5 neurological disorders of the brain, that it is treatable and not a condition to be stigmatized. However, the tools to diagnose epilepsy (clinical knowledge, EEG capability, imaging on a case-by-case basis, blood work to diagnose treatable metabolic disorders associated with seizures) are not uniformly available. Long term surveillance to increase knowledge about outcomes doesn’t exist.
How does stigma around epilepsy continue to affect patient outcomes in practice, and what role can pediatric neurologists play in reducing its impact on patients and their families?
Stigma associated with epilepsy is a huge barrier to patient outcomes. As a first step, hiding the fact that someone has epilepsy prevents the patient from getting access to diagnosis, further investigation and appropriate treatment. Stigma can also stem preventive treatment in the form of better overall heath because preventive causes of epilepsy include birth trauma, stroke, and infections.
It is important to send the message that epilepsy is not contagious, that it is treatable in 70% of cases, that causes of epilepsy (like meningitis, birth trauma, stroke) are preventable. Antiseizure medications are affordable. Patients with epilepsy can and should be allowed to lead a normal life. Child neurologists should take an active role in educating locally at camps, schools, sporting organizations, small community groups, canvassing for greater resources for themselves and their patients at the community level, as well as regional and national levels.
Where do you see the greatest unmet needs in pediatric epilepsy research globally, and how could addressing these gaps meaningfully change clinical practice and patient quality of life?
As has already been established by WHO’s Intersectoral Global Action Plan on Epilepsy; robust epidemiological data on epilepsy are missing in most countries, lived experiences of people with epilepsy are not heard. Obtaining more information on indicators for quality of life of people with epilepsy will drive meaningful research.
One of the first steps in getting there is increasing access to care for EVERYONE with epilepsy irrespective of where they are born or live in the world. This can be achieved by a dedicated plan to train more practitioners to become comfortable with treating epilepsy while increasing capacity to train more child neurologists. Many of us are contributing our time to produce lectures that learners can access on digital platforms; and from case discussions online to improve overall education.
Transcript edited for clarity.
REFERENCES
1. Mehndiratta MM, Wadhai SA. International Epilepsy Day - A day notified for global public education & awareness. Indian J Med Res. 2015 Feb;141(2):143-4. doi: 10.4103/0971-5916.155531. PMID: 25900945; PMCID: PMC4418146.
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.










